U.S Intravenous Solution Market Size Share Trends Forecast 2026

1. U.S. INTRAVENOUS SOLUTIONS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION U.S Intravenous Solution Market - Overview U.S Intravenous Solution Market, by Solution Type (Saline (Normal saline 0.9% NaCl and Hypertonic saline), Dextran (D5W 5% dextrose in water and Analog Hypertonic Saline), Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and trace elements, and Mixed Solutions), By Packaging (Ampules, Vials, Cartridges, Bottles, Bags (Large Volume Bags-greater than 250ml and Small Volume Bags-less than 250ml), By Indication (Oncology, Post-Operative Care, General Medicine, Burn Management, Pulmonary Disorders, Cardiovascular Diseases, and Others), and By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home care Settings, and Others) is estimated to be valued at US$ 2,811.3 million in 2021 and is expected to exhibit a CAGR of 6.1% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights. U.S Intravenous Solutions Market- Impact of Coronavirus (COVID-19) Pandemic Lockdown in various countries due to the pandemic has placed an economic burden on the private healthcare sector. Healthcare providers are facing challenges with regards to declining outpatient’s visits, manpower, equipment, consumables, and other resources to ensure safety in treatment of patients with other diseases. The global COVID-19 pandemic has sharply focused the attention of the world onto critical care of COVID-19 patients. During the early stages of the COVID-19 pandemic, it was a common advice of physicians to aim for a negative fluid balance. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/us- intravenous-solution-market-3400 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION However, the increasing number of product approvals from regulatory bodies, collaborations and partnership strategies adopted by key players are some of the major factors which are expected to drive growth of the U.S intravenous solution market during the forecast period. For instance, in November 2016, Mallinckrodt Pharmaceuticals received U.S. Food and Drug Administration’s (FDA) Prior Approval Supplement for its OFIRMEV (acetaminophen) injection (new drug application) available in an intravenous (IV) bag presentation. Administration of IV fluids in the patients of cardiac arrhythmia helps in improvement of haemodynamic status in critically ill patients. Thus, the increasing number prevalence of cardiac arrhythmia is expected to provide huge opportunities to the U.S intravenous solution market growth in the near future. For instance, the Centers for Disease Control and Prevention 2014, estimated that 2.7–6.1 million people in the U.S. suffered from atrial fibrillation. With increasing aging population, this number is also expected to increase. The increasing number of patient admissions in ambulatory surgical centers for surgical procedures, which requires intravenous solutions or infusion for administration of drugs is expected to drive the ambulatory surgical centers (ASCs) segment growth. For instance, according to the H-Cup Journal Report 2017, in the U.S., there were around 17.2 million ambulatory hospital visits recorded in the hospitals. A person suffering from diarrhea also suffers from intense fluid loss and dehydration. Thus, diarrhea patients are highly prescribed with IV fluids such as saline and vitamins. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3400 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION The increasing number of surgeries are expected to propel demand for large volume of Intravenous (IV) solutions. For instance, according to Healthcare Cost and Utilization Project report 2020, a total of 17.2 million hospital visits (as visits or inpatient stays) in the United States included at least one surgery in 2017. Key Takeaways of the U.S Intravenous Solution Market: The U.S intravenous solution market is expected to exhibit a CAGR of 6.1% during the forecast period (2021-2028) owing to the increasing launches of new intravenous solution injections for the treatment of various issues such as neuromuscular blockade and paralysis, this is expected to boost the market growth over the forecast period. For instance, in 2017, Fresenius Kabi USA, LLC, a provider of medicines and technologies for infusion, transfusion, and clinical nutrition, launched Vecuronium Bromide IV injection in the U.S. The drug is indicated for maintenance of neuromuscular blockade and paralysis. Among solution type, Saline segment is expected to hold major revenue share in 2028, owing to the increasing incidence of gastroenteritis, which is expected to contribute to the growth of the saline segment. For instance, according to the data of National Center of Biotechnology Information 2020, acute viral gastroenteritis accounts for 19 to 21 million cases of diarrheal illnesses annually in the U.S. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3400 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved